Aspect Biosystems

Bioprinting Tissue Therapeutics

Vancouver, Canada · Founded 2013 · $202.8M raised

Headquarters
Vancouver
Employees
51–200
Founded
2013
Business Model
B2B
Total Funding
$202.8M
Last Round
$115.0M Series BJan 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Aspect Biosystems is a Canadian biotechnology company founded in 2013 at the University of British Columbia, pioneering the development of bioprinted tissue therapeutics. The company uses proprietary microfluidic bioprinting technology to create implantable tissues designed to replace, repair, or supplement biological function. Their lead programs target metabolic and endocrine diseases, and they have partnered with Novo Nordisk and raised over US$350M in capital.

Summary

Aspect Biosystems is a Biotech company based in Vancouver, Canada, founded in 2013. It has raised $202.8M in total across 3 rounds, most recently a $115.0M Series B round in Jan 2025. Investors include Dimension Capital, Government of Canada and Government of British Columbia.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJan 2025
$115.0M

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Aspect Biosystems on Indexed.vc
<a href="https://indexed.vc/companies/aspect-biosystems"><img src="https://indexed.vc/api/badge/company/aspect-biosystems" alt="Aspect Biosystems on Indexed.vc" width="260" height="76" /></a>